Literature DB >> 30649651

Clinical melanoma characteristics and survival-a single-center retrospective study between 2000 and 2010.

Valentin Feichtenschlager1,2, Felix Weihsengruber3, Leo Richter3, Igor Vujic3,4, Klemens Rappersberger3,4, Christian Posch3,4,5.   

Abstract

The aim of this study was to characterize clinical, histological, and outcome features of primary melanoma in 1329 patients managed at a single-center institution between 2000 and 2010. Parameters included age at diagnosis, sex, tumor location, histology, stage, Breslow thickness, and sentinel lymph node status among others. The mean age at diagnosis was 59.1 ± 16.7 years. Women were significantly younger than men when diagnosed (57.2 vs. 61.0 years; p < 0.001). Most melanomas (83%) were diagnosed on typically sun-exposed skin areas. Superficial spreading melanoma (39.5%) was the most frequent histological subtype. The median Breslow thickness was significantly higher for men compared to women (1.10 mm vs. 0.90 mm; p = 0.018). 38.3% of patients with positive and 12.9% of patients with negative sentinel biopsies progressed. Five-year survival analysis for a sub-cohort of 577 patients showed better 5‑year overall survival for woman compared to men (75.8% vs. 63.6%; p = 0.025). Our findings indicate differences in patient characteristics between men and women, and underscore the importance of early melanoma detection to prevent disease progression.

Entities:  

Keywords:  Austria; Diagnosis; Melanoma; Sex distribution; Survival

Mesh:

Year:  2019        PMID: 30649651     DOI: 10.1007/s10354-018-0678-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  13 in total

1.  Melanoma recurrence patterns after negative sentinel lymphadenectomy.

Authors:  Theresa G Zogakis; Richard Essner; He-jing Wang; Roderick R Turner; Yuki T Takasumi; Robin L Gaffney; Jonathan H Lee; Donald L Morton
Journal:  Arch Surg       Date:  2005-09

2.  The objective assessment of lifetime cumulative ultraviolet exposure for determining melanoma risk.

Authors:  Zaria Tatalovich; John P Wilson; Thomas Mack; Ying Yan; Myles Cockburn
Journal:  J Photochem Photobiol B       Date:  2006-09-11       Impact factor: 6.252

3.  Patterns of detection in patients with cutaneous melanoma.

Authors:  M S Brady; S A Oliveria; P J Christos; M Berwick; D G Coit; J Katz; A C Halpern
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

4.  A ten-year analysis of demographic trends for cutaneous melanoma: analysis of 2501 cases treated at the University Department of Dermatology in Vienna (1990-1999).

Authors:  H Kittler; M Binder; K Wolff; H Pehamberger
Journal:  Wien Klin Wochenschr       Date:  2001-04-30       Impact factor: 1.704

5.  [Clinical epidemiologic data of malignant melanoma based on 1,368 patients of the Graz University Dermatology Clinic (1970-1989)].

Authors:  E Rieger; H P Soyer; R Kofler; S Hödl; J Smolle; E Richtig; H Kerl
Journal:  Wien Klin Wochenschr       Date:  1991       Impact factor: 1.704

Review 6.  Gender-linked differences in human skin.

Authors:  Paolo U Giacomoni; Thomas Mammone; Matthew Teri
Journal:  J Dermatol Sci       Date:  2009-07-01       Impact factor: 4.563

7.  Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.

Authors:  C Garbe; C E Orfanos
Journal:  Pigment Cell Res       Date:  1992

Review 8.  Metastatic melanoma in the older patient: special considerations.

Authors:  Upendra P Hegde; Jane M Grant-Kels
Journal:  Clin Dermatol       Date:  2013 May-Jun       Impact factor: 3.541

9.  The burden of malignant melanoma--lessons to be learned from Austria.

Authors:  Babak Monshi; Marin Vujic; Danijel Kivaranovic; Alma Sesti; Willi Oberaigner; Igor Vujic; Susana Ortiz-Urda; Christian Posch; Hans Feichtinger; Monika Hackl; Klemens Rappersberger
Journal:  Eur J Cancer       Date:  2016-01-20       Impact factor: 9.162

10.  Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009).

Authors:  Caroline Biver-Dalle; Eve Puzenat; Marc Puyraveau; Delphine Delroeux; Hatem Boulahdour; Frances Sheppard; Fabien Pelletier; Philippe Humbert; François Aubin
Journal:  BMC Dermatol       Date:  2012-12-10
View more
  1 in total

1.  Randomized controlled trial of the mySmartSkin web-based intervention to promote skin self-examination and sun protection behaviors among individuals diagnosed with melanoma: study design and baseline characteristics.

Authors:  Elliot J Coups; Sharon L Manne; Pamela Ohman Strickland; Michelle Hilgart; James S Goydos; Carolyn J Heckman; Paola Chamorro; Babar K Rao; Moira Davis; Franz O Smith; Frances P Thorndike; Lee M Ritterband
Journal:  Contemp Clin Trials       Date:  2019-06-27       Impact factor: 2.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.